{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:22:02Z","timestamp":1791451322339,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.transproceed.2019.04.068","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T20:07:40Z","timestamp":1564171660000},"page":"2268-2273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience"],"prefix":"10.1016","volume":"51","author":[{"given":"Ayse","family":"Sinangil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal Atan","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yener","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soykan","family":"Barlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Abouzahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman Tevfik","family":"Ecder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin Baris","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.04.068_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-018-0039-x","article-title":"HLA in transplantation","volume":"14","author":"Montgomery","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.068_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/1744666X.2018.1498335","article-title":"Transplantation in highly sensitized patients: challenges and recommendations","volume":"14","author":"Heidt","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.transproceed.2019.04.068_bib3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/01.TP.0000442782.98131.7c","article-title":"Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch","volume":"97","author":"Riella","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.04.068_bib4","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.transproceed.2012.04.006","article-title":"Recent developments in desensitization of crossmatch-positive kidney transplant recipients","volume":"44","author":"Morath","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.04.068_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.068_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.04.068_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-6143.2008.02524.x","article-title":"Positive cross-match living donor kidney transplantation: longer-term outcomes","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.transproceed.2019.04.068_bib9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.068_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.068_bib11","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.068_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation","volume":"3","author":"Gloor","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A\u00a0comparison of plasmapheresis vs high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJMe1601379","article-title":"HLA-incompatible kidney transplantation\u2014worth the risk?","volume":"374","author":"Rostaing","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.068_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(16)31595-1","article-title":"Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis","volume":"389","author":"Manook","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.04.068_bib16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.kint.2017.04.004","article-title":"Are sensitized patients better off with a desensitization transplant or waiting on dialysis?","volume":"91","author":"Clayton","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.068_bib17","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/tri.12832","article-title":"Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab","volume":"29","author":"Kahwaji","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2019.04.068_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.04.068_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.068_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.068_bib21","first-page":"85","article-title":"Complement-binding anti-HLA antibodies and kidney transplantation","volume":"370","author":"Lefaucheur","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.068_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14656566.8.7.913","article-title":"Antibody-mediated rejection following renal transplantation","volume":"8","author":"Sureshkumar","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.transproceed.2019.04.068_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.04.068_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/tri.12267","article-title":"Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment","volume":"27","author":"Ishida","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2019.04.068_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1432-2277.2012.01518.x","article-title":"Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection","volume":"25","author":"Hirai","year":"2012","journal-title":"Transpl Int"},{"issue":"suppl. 5","key":"10.1016\/j.transproceed.2019.04.068_bib27","first-page":"427","article-title":"Combined induction therapy with rabbit antithymocyte globulin (RATG) and rituximab (RTX) in highly sensitized kidney recipients: long-term outcomes [abstract]","volume":"13","author":"Laftavi","year":"2013","journal-title":"Am J Transplant (AJT)"},{"issue":"Suppl. 2","key":"10.1016\/j.transproceed.2019.04.068_bib28","first-page":"487","article-title":"Highly sensitized kidney recipients (PRA980%) benefit from rabbit antithymocyte globulin (rATG) and rituximab induction therapy [abstract]","volume":"11","author":"Laftavi","year":"2011","journal-title":"Am J Transplant (AJT)"},{"key":"10.1016\/j.transproceed.2019.04.068_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000435924","article-title":"Effect of pretransplant rituximab use on posttransplant clinical outcomes in patients with high panel reactive antibody scores","volume":"130","author":"Hwang","year":"2015","journal-title":"Nephron"},{"issue":"Suppl. 3","key":"10.1016\/j.transproceed.2019.04.068_bib30","first-page":"151","article-title":"Post-transplant desensitization with IVIg\/anti-CD20\/plasmapheresis in DSA+ kidney recipients decreases CAMR incidence [abstract]","volume":"12","author":"Amrouche","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.068_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ctr.12335","article-title":"Desensitization in kidney transplantation: review and future perspectives","volume":"28","author":"Jawdeh","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-6143.2009.03001.x","article-title":"Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols","volume":"10","author":"Montgomery","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.068_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.transproceed.2012.08.007","article-title":"Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of 5 cases","volume":"45","author":"Yabu","year":"2013","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518316671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518316671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:30:32Z","timestamp":1758576632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518316671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0041134518316671"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.068","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}